151 related articles for article (PubMed ID: 23244326)
1. Preparation and characterization of monoclonal antibody against glypican-3.
Ma RJ; Wang SH; Qin SN; Wang XB; Li GF; Li M; Xu WW
Hybridoma (Larchmt); 2012 Dec; 31(6):455-61. PubMed ID: 23244326
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of monoclonal antibody against translationally controlled tumor protein.
Qiang M; Fenfang W; Yan G; Wen S; Maoliang H; Yingsong W; Weiwen X; Ming L
Hybridoma (Larchmt); 2011 Feb; 30(1):81-5. PubMed ID: 21466289
[TBL] [Abstract][Full Text] [Related]
3. Preparation of a monoclonal antibody against the carcinoembryonic antigen, glypican‑3.
Zhang Y; Qiu D; Li R; Liu Y; Shi S; Wang Y
Mol Med Rep; 2019 May; 19(5):3889-3895. PubMed ID: 30896845
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody preparation of Golgi phosphoprotein 2 and preliminary application in the early diagnosis of hepatocellular carcinoma.
Ju Q; Zhao Y; Liu Y; Zhou G; Li F; Xie P; Li Y; Li GC
Mol Med Rep; 2013 Aug; 8(2):517-22. PubMed ID: 23727927
[TBL] [Abstract][Full Text] [Related]
5. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis.
Yu J; Ma Q; Zhang B; Ma R; Xu X; Li M; Xu W; Li M
Sci China Life Sci; 2013 Mar; 56(3):234-9. PubMed ID: 23526389
[TBL] [Abstract][Full Text] [Related]
6. Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3.
Chen JJ; Xie CM; Wang CR; Wan Y; Dong ZN; Li M; Xu WW
J Fluoresc; 2017 Jul; 27(4):1479-1485. PubMed ID: 28429175
[TBL] [Abstract][Full Text] [Related]
7. High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening.
Phung Y; Gao W; Man YG; Nagata S; Ho M
MAbs; 2012; 4(5):592-9. PubMed ID: 22820551
[TBL] [Abstract][Full Text] [Related]
8. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
Yamauchi N; Watanabe A; Hishinuma M; Ohashi K; Midorikawa Y; Morishita Y; Niki T; Shibahara J; Mori M; Makuuchi M; Hippo Y; Kodama T; Iwanari H; Aburatani H; Fukayama M
Mod Pathol; 2005 Dec; 18(12):1591-8. PubMed ID: 15920546
[TBL] [Abstract][Full Text] [Related]
9. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma.
Capurro M; Wanless IR; Sherman M; Deboer G; Shi W; Miyoshi E; Filmus J
Gastroenterology; 2003 Jul; 125(1):89-97. PubMed ID: 12851874
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of a novel oncofetal antigen, glypican-3, for diagnosis and immunotherapy of hepatocellular carcinoma].
Nishimura Y; Nakatsura T; Senju S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):383-91. PubMed ID: 18974622
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of a high-affinity monoclonal antibody for MUC1 measurement in breast cancer.
Hamid SS; Cheah SH
Hybridoma (Larchmt); 2011 Apr; 30(2):137-43. PubMed ID: 21529286
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal antibody production against rGPC3 and their application in diagnosis of hepatocellular carcinoma.
Wang S; Kalim M; Liang K; Zhan J
Prep Biochem Biotechnol; 2018 May; 48(5):435-445. PubMed ID: 29561231
[TBL] [Abstract][Full Text] [Related]
13. Identification of nanobodies against hepatocellular carcinoma marker glypican-3.
Wang W; Xu C; Wang H; Jiang C
Mol Immunol; 2021 Mar; 131():13-22. PubMed ID: 33453658
[TBL] [Abstract][Full Text] [Related]
14. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
[TBL] [Abstract][Full Text] [Related]
15. The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regulator 2.
Morford LA; Davis C; Jin L; Dobierzewska A; Peterson ML; Spear BT
Hepatology; 2007 Nov; 46(5):1541-7. PubMed ID: 17668883
[TBL] [Abstract][Full Text] [Related]
16. GPC3 DNA vaccine elicits potent cellular antitumor immunity against HCC in mice.
Li SQ; Lin J; Qi CY; Fu SJ; Xiao WK; Peng BG; Liang LJ
Hepatogastroenterology; 2014; 61(130):278-84. PubMed ID: 24901124
[TBL] [Abstract][Full Text] [Related]
17. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies against NS4B protein of japanese encephalitis virus.
Ruan X; Huang S; Shao L; Ye J; Chen Z; Chen H; Cao S
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):382-5. PubMed ID: 24328740
[TBL] [Abstract][Full Text] [Related]
19. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
Kandil DH; Cooper K
Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
[TBL] [Abstract][Full Text] [Related]
20. Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization.
Nakano K; Ishiguro T; Konishi H; Tanaka M; Sugimoto M; Sugo I; Igawa T; Tsunoda H; Kinoshita Y; Habu K; Orita T; Tsuchiya M; Hattori K; Yamada-Okabe H
Anticancer Drugs; 2010 Nov; 21(10):907-16. PubMed ID: 20847643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
